On March 27, 2026, PAVmed Inc. held a special meeting of its stockholders, where significant corporate actions were approved. Stockholders representing approximately 54.1% of the voting power were present, indicating a strong engagement in the decision-making process. The proposals included the issuance of shares of common stock upon conversion of Series D Convertible Preferred Stock and an amendment to the company's certificate of incorporation allowing for the removal of directors by a majority vote. Additionally, an amendment to the 2014 Long-Term Incentive Equity Plan was approved, increasing the total number of shares available under the plan by 1,500,000 shares. These actions are expected to enhance the company's capital structure and provide greater flexibility in its operations. The approval of these proposals reflects the confidence of stockholders in the company's strategic direction and governance.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.